Tag: pharmaceuticals

NeuroSense CEO Alon Ben-Noon presenting PrimeC first generation. Photo courtesy of NeuroSense

Promising new drug could slow progression of ALS

A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup developing a drug combo that aims to slow progression of ALS and other neurodegenerative diseases.